Study Evaluates Clinical Value of Stroke Biomarkers

Admission glucose level appears to be a strong predictor of poor outcomes

FRIDAY, Feb. 17 (HealthDay News) -- While 136 different stroke biomarkers have been identified, the clinical value of these biomarkers remains unclear, according to a study published online Feb. 9 in the British Journal of Clinical Pharmacology.

Nazeeha Hasan, of the Imperial College in London, and colleagues conducted a systematic review of 141 relevant studies to identify diagnostic and prognostic biomarkers in acute ischemic and hemorrhagic stroke and to find those likely to predict complications following thrombolysis.

The researchers found that three markers -- C-reactive protein, P-selectin, and homocysteine -- significantly differentiated between ischemic stroke patients and healthy controls. Levels of glial fibrillary acidic protein differed significantly between hemorrhagic stroke and ischemic stroke patients (mean difference [MD], 224.58 ng/L). High levels of glucose at admission were a strong predictor of poor prognosis after ischemic stroke and symptomatic intracerebral hemorrhage post-thrombolysis. In addition, glutamate was found to be a significant indicator of progressive (unstable) stroke (MD, 172.65 µmol/L); D-dimer significantly predicted in-hospital death (MD, 0.67 µg/mL); and high fibrinogen levels were significantly associated with poor outcome at three months following ischemic stroke (MD, 47.90 mg/L).

"Few biomarkers currently investigated have meaningful clinical value. Admission glucose may be a strong marker of poor prognosis following acute thrombolytic treatment," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95


Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95


Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events